UniProt ID | LYN_RAT | |
---|---|---|
UniProt AC | Q07014 | |
Protein Name | Tyrosine-protein kinase Lyn | |
Gene Name | Lyn | |
Organism | Rattus norvegicus (Rat). | |
Sequence Length | 512 | |
Subcellular Localization |
Cell membrane. Nucleus. Cytoplasm. Cytoplasm, perinuclear region. Golgi apparatus. Membrane Lipid-anchor . Accumulates in the nucleus by inhibition of Crm1-mediated nuclear export. Nuclear accumulation is increased by inhibition of its kinase activ |
|
Protein Description | Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors and cytokines, integrin signaling, but also responses to DNA damage and genotoxic agents. Functions primarily as negative regulator, but can also function as activator, depending on the context. Required for the initiation of the B-cell response, but also for its down-regulation and termination. Plays an important role in the regulation of B-cell differentiation, proliferation, survival and apoptosis, and is important for immune self-tolerance. Acts downstream of several immune receptors, including the B-cell receptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A, TLR2 and TLR4. Plays a role in the inflammatory response to bacterial lipopolysaccharide. Mediates the responses to cytokines and growth factors in hematopoietic progenitors, platelets, erythrocytes, and in mature myeloid cells, such as dendritic cells, neutrophils and eosinophils. Acts downstream of EPOR, KIT, MPL, the chemokine receptor CXCR4, as well as the receptors for IL3, IL5 and CSF2. Plays an important role in integrin signaling. Regulates cell proliferation, survival, differentiation, migration, adhesion, degranulation, and cytokine release. Down-regulates signaling pathways by phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIM), that then serve as binding sites for phosphatases, such as PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1, that modulate signaling by dephosphorylation of kinases and their substrates. Phosphorylates LIME1 in response to CD22 activation. Phosphorylates BTK, CBL, CD5, CD19, CD72, CD79A, CD79B, CSF2RB, DOK1, HCLS1, LILRB3/PIR-B, MS4A2/FCER1B, PTK2B/PYK2, SYK and TEC. Promotes phosphorylation of SIRPA, PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1. Required for rapid phosphorylation of FER in response to FCER1 activation. Mediates KIT phosphorylation. Acts as an effector of EPOR (erythropoietin receptor) in controlling KIT expression and may play a role in erythroid differentiation during the switch between proliferation and maturation. Depending on the context, activates or inhibits several signaling cascades. Regulates phosphatidylinositol 3-kinase activity and AKT1 activation. Regulates activation of the MAP kinase signaling cascade, including activation of MAP2K1/MEK1, MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1 and MAPK9/JNK2. Mediates activation of STAT5A and/or STAT5B (By similarity). Phosphorylates LPXN on 'Tyr-72' (By similarity). Kinase activity facilitates TLR4-TLR6 heterodimerization and signal initiation.. | |
Protein Sequence | MGCIKSKRKDNLNDDGVDMKTQPVRNTDRTIYVRDPTSNKQQRPVPESQLLPGQRFQAKDPEEQGDIVVALYPYDGIHPDDLSFKKGEKMKVLEEHGEWWKAKSLSSKREGFIPSNYVAKVNTLETEEWFFKDITRKDAERQLLAPGNSAGAFLIRESETLKGSFSLSVRDYDPMHGDVIKHYKIRSLDNGGYYISPRITFPCISDMIKHYQKQSDGLCRRLEKACISPKPQKPWDKDAWEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSAQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGSKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRMENCPDELYDIMKMCWKESAEERPTFDYLQSVLDDFYTATEGQYQQQP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGCIKSKRK ------CCCCCCCCC | 23.12 | - | |
3 | S-palmitoylation | -----MGCIKSKRKD -----CCCCCCCCCC | 3.23 | - | |
20 | Ubiquitination | NDDGVDMKTQPVRNT CCCCCCCCCCCCCCC | 39.27 | - | |
32 | Phosphorylation | RNTDRTIYVRDPTSN CCCCCEEEEECCCCC | 6.71 | - | |
37 | Phosphorylation | TIYVRDPTSNKQQRP EEEEECCCCCCCCCC | 49.58 | 25575281 | |
38 | Phosphorylation | IYVRDPTSNKQQRPV EEEECCCCCCCCCCC | 47.63 | 25575281 | |
48 | Phosphorylation | QQRPVPESQLLPGQR CCCCCCHHHCCCCCC | 21.76 | 25575281 | |
181 | Acetylation | PMHGDVIKHYKIRSL CCCCCEEEEEEEEEC | 40.50 | 22902405 | |
187 | Phosphorylation | IKHYKIRSLDNGGYY EEEEEEEECCCCCEE | 43.48 | 28689409 | |
193 | Phosphorylation | RSLDNGGYYISPRIT EECCCCCEEECCCEE | 10.06 | 28689409 | |
194 | Phosphorylation | SLDNGGYYISPRITF ECCCCCEEECCCEEC | 9.74 | 28689409 | |
196 | Phosphorylation | DNGGYYISPRITFPC CCCCEEECCCEECCC | 7.63 | 30181290 | |
213 | Acetylation | DMIKHYQKQSDGLCR HHHHHHHHHCCCHHH | 44.60 | 22902405 | |
228 | Phosphorylation | RLEKACISPKPQKPW HHHHHHCCCCCCCCC | 27.10 | - | |
248 | Acetylation | EIPRESIKLVKKLGA CCCHHHHHHHHHHCC | 57.41 | 22902405 | |
306 | Phosphorylation | HDKLVRLYAVVTKEE HCCCEEEEEEECCCC | 6.18 | - | |
316 | Phosphorylation | VTKEEPIYIITEFMA ECCCCCEEEEEEHHH | 9.29 | 22673903 | |
397 | Phosphorylation | RVIEDNEYTAREGAK EEEECCCEECCCCCC | 16.38 | 22108457 | |
398 | Phosphorylation | VIEDNEYTAREGAKF EEECCCEECCCCCCC | 17.04 | 30181290 | |
460 | Phosphorylation | MTALSQGYRMPRMEN HHHHHCCCCCCCCCC | 8.97 | - | |
473 | Phosphorylation | ENCPDELYDIMKMCW CCCCHHHHHHHHHHH | 11.02 | - | |
495 | Phosphorylation | PTFDYLQSVLDDFYT CCHHHHHHHHHHHHH | 23.27 | 22673903 | |
501 | Phosphorylation | QSVLDDFYTATEGQY HHHHHHHHHHCCCCC | 11.49 | 27097102 | |
502 | Phosphorylation | SVLDDFYTATEGQYQ HHHHHHHHHCCCCCC | 27.39 | 27097102 | |
504 | Phosphorylation | LDDFYTATEGQYQQQ HHHHHHHCCCCCCCC | 32.61 | 27097102 | |
508 | Phosphorylation | YTATEGQYQQQP--- HHHCCCCCCCCC--- | 21.10 | 27097102 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
397 | Y | Phosphorylation | Kinase | LYN | Q07014 | GPS |
508 | Y | Phosphorylation | Kinase | CSK | P32577 | Uniprot |
508 | Y | Phosphorylation | Kinase | LYN | Q07014 | GPS |
508 | Y | Phosphorylation | Kinase | MATK | P41243 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LYN_RAT !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LYN_RAT !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
UBC_RAT | Ubc | physical | 14531861 | |
UBC_RAT | Ubc | physical | 11137137 | |
LYN_RAT | Lyn | physical | 14604964 | |
ENOA_HUMAN | ENO1 | physical | 14604964 | |
SYUA_HUMAN | SNCA | physical | 11744621 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Spontaneous autophosphorylation of Lyn tyrosine kinase at both itsactivation segment and C-terminal tail confers altered substratespecificity."; Donella-Deana A., Cesaro L., Ruzzene M., Brunati A.M., Marin O.,Pinna L.A.; Biochemistry 37:1438-1446(1998). Cited for: PHOSPHORYLATION AT TYR-397 AND TYR-508, CATALYTIC ACTIVITY,AUTOPHOSPHORYLATION, ENZYME REGULATION, AND TISSUE SPECIFICITY. |